Page last updated: 2024-10-28

hydroxychloroquine and Bartonella bacilliformis Infection

hydroxychloroquine has been researched along with Bartonella bacilliformis Infection in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durey, A1
Kwon, HY1
Im, JH1
Lee, SM1
Baek, J1
Han, SB1
Kang, JS1
Lee, JS1

Other Studies

1 other study available for hydroxychloroquine and Bartonella bacilliformis Infection

ArticleYear
Bartonella henselae infection presenting with a picture of adult-onset Still's disease.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 46

    Topics: Adult; Bartonella henselae; Bartonella Infections; Female; Humans; Hydroxychloroquine; Male; Still's

2016